NAD+ deficiency and mitochondrial dysfunction in granulosa cells of women with polycystic ovary syndrome‡
- 29 May 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 105 (2) , 371-380
Abstract
Polycystic ovary syndrome (PCOS) is a prevalent heterogeneous endocrine disorder characterized by ovulation dysfunction, androgen excess, ovarian polycystic changes, insulin resistance, and infertility. Although underlying mechanisms for PCOS are still unknown, inflammation and mitochondrial dysfunction in granulosa cells (GCs) of PCOS patients have been reported. Here, we found that Nicotinamide Adenine Dinucleotide (NAD+) levels in GCs of PCOS patients was significantly decreased when compared with controls. Also, we found that higher expression of inflammation factors, increased reactive oxygen species (ROS) accumulation, lower adenosine triphosphate (ATP) generation, and decreased mitochondrial membrane potential, as well as abnormal mitochondrial dynamics in GCs of PCOS patients. In addition, the NAD+ levels were decreased after activation of inflammation in human granulosa-like tumor cell line (KGN) treated by Lipopolysaccharide (LPS). However, supplementation of nicotinamide riboside (NR), a NAD+ precursor, could largely restore the NAD+ content, reduce ROS levels and improve mitochondrial function demonstrated by increased mitochondrial membrane potential and ATP generation in LPS-treated KGN cells. Our data suggested that inflammation decreased NAD+ levels in GCs of PCOS patients, while supplementation of NR could restore NAD+ levels and alleviated mitochondrial dysfunction in GCs of PCOS patients.Keywords
Funding Information
- National Natural Science Foundation of China (31970800)
- Key Program for International Science and Technology Cooperation Projects of China (81820108016)
- National Key R&D Program of China (2019YFA0110900)
This publication has 41 references indexed in Scilit:
- Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndromeJournal of Cellular Physiology, 2018
- Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndromeReproduction, 2015
- Up-Regulated Expression of WNT5a Increases Inflammation and Oxidative Stress via PI3K/AKT/NF-κB Signaling in the Granulosa Cells of PCOS PatientsThe Journal of Clinical Endocrinology & Metabolism, 2015
- Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysisHuman Reproduction Update, 2013
- Indices of Low‐Grade Inflammation in Polycystic Ovary SyndromeAnnals of the New York Academy of Sciences, 2006
- Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apneaMetabolism, 2006
- Increased Activation of Nuclear Factor κB Triggers Inflammation and Insulin Resistance in Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2006
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertility and Sterility, 2004
- Apoptosis within bovine follicular cells and its effect on oocyte development during in vitro maturationTheriogenology, 2003
- Aromatase activity in human granulosa cells during follicular development and the modulation by follicle-stimulating hormone and insulinAmerican Journal of Obstetrics and Gynecology, 1984